Literature DB >> 23408185

Evaluation of mini-mental status examination score after gamma knife radiosurgery as the first radiation treatment for brain metastases.

Kiyoshi Nakazaki1, Hideyuki Kano.   

Abstract

This study evaluated the mini-mental status examination (MMSE) scores of patients with brain metastases after gamma knife radiosurgery (GKS) without whole-brain radiation therapy (WBRT). Between January 2009 and June 2011, 119 consecutive patients with new brain metastases were treated with a single session of GKS without WBRT. MMSE scores were determined for all patients before GKS and for surviving patients every 3 months after GKS. We evaluated 76 patients (63.9 %) after GKS. The median pre-GKS MMSE score was 28 (range 3-30). The median age, number of brain metastases, and total volume of brain metastases were 65.5 years (range 40-92 years), 2 (range 1-18), and 4.17 ml (range 0.04-27.0 ml), respectively. The median marginal dose was 22.0 Gy (range 14-24 Gy). Thirty-nine patients (51.3 %) developed new distant lesions. The median MMSE follow-up time was 5.8 months (range 0.9-21.6 months). In 16 of 37 patients (43.2 %) with pre-GKS MMSE scores ≤27, the MMSE scores improved by ≥3 points, whereas 15 of all patients (19.7 %) experienced deteriorations of ≥3 points. The incidences of 3-point drops due to new distant lesions and adverse radiation effects were 2.6 and 1.3 %, respectively. The 12-month rate of 3-point drops of the MMSE score due to these 2 causes was 4.2 % (1 of 24 patients). A larger tumor volume was a better prognostic factor for an improvement. GKS has a mild effect on neurocognitive function. Mental deterioration of patients with large symptomatic metastatic tumors tended to improve after GKS.

Entities:  

Mesh:

Year:  2013        PMID: 23408185     DOI: 10.1007/s11060-013-1071-0

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  17 in total

1.  Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial.

Authors:  Hidefumi Aoyama; Hiroki Shirato; Masao Tago; Keiichi Nakagawa; Tatsuya Toyoda; Kazuo Hatano; Masahiro Kenjyo; Natsuo Oya; Saeko Hirota; Hiroki Shioura; Etsuo Kunieda; Taisuke Inomata; Kazushige Hayakawa; Norio Katoh; Gen Kobashi
Journal:  JAMA       Date:  2006-06-07       Impact factor: 56.272

2.  Neurocognitive function of patients with brain metastasis who received either whole brain radiotherapy plus stereotactic radiosurgery or radiosurgery alone.

Authors:  Hidefumi Aoyama; Masao Tago; Norio Kato; Tatsuya Toyoda; Masahiro Kenjyo; Saeko Hirota; Hiroki Shioura; Taisuke Inomata; Etsuo Kunieda; Kazushige Hayakawa; Keiichi Nakagawa; Gen Kobashi; Hiroki Shirato
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-08-01       Impact factor: 7.038

3.  Adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases: results of the EORTC 22952-26001 study.

Authors:  Martin Kocher; Riccardo Soffietti; Ufuk Abacioglu; Salvador Villà; Francois Fauchon; Brigitta G Baumert; Laura Fariselli; Tzahala Tzuk-Shina; Rolf-Dieter Kortmann; Christian Carrie; Mohamed Ben Hassel; Mauri Kouri; Egils Valeinis; Dirk van den Berge; Sandra Collette; Laurence Collette; Rolf-Peter Mueller
Journal:  J Clin Oncol       Date:  2010-11-01       Impact factor: 44.544

4.  Memory function before and after whole brain radiotherapy in patients with and without brain metastases.

Authors:  Grit Welzel; Katharina Fleckenstein; Jörg Schaefer; Brigitte Hermann; Uta Kraus-Tiefenbacher; Sabine K Mai; Frederik Wenz
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-04-28       Impact factor: 7.038

5.  Delayed cyst formation after gamma knife radiosurgery for brain metastases.

Authors:  Eiichi Ishikawa; Masaaki Yamamoto; Atsushi Saito; Yuji Kujiraoka; Tatsuo Iijima; Hiroyoshi Akutsu; Akira Matsumura
Journal:  Neurosurgery       Date:  2009-10       Impact factor: 4.654

6.  Gamma Knife surgery as sole treatment for multiple brain metastases: 2-center retrospective review of 1508 cases meeting the inclusion criteria of the JLGK0901 multi-institutional prospective study.

Authors:  Toru Serizawa; Masaaki Yamamoto; Yasunori Sato; Yoshinori Higuchi; Osamu Nagano; Takuya Kawabe; Shinji Matsuda; Junichi Ono; Naokatsu Saeki; Manabu Hatano; Tatsuo Hirai
Journal:  J Neurosurg       Date:  2010-12       Impact factor: 5.115

7.  Timing and risk factors for new brain metastasis formation in patients initially treated only with Gamma Knife surgery. Clinical article.

Authors:  Jason P Sheehan; Chun-Po Yen; James Nguyen; Jessica A Rainey; Kasandra Dassoulas; David J Schlesinger
Journal:  J Neurosurg       Date:  2010-03-12       Impact factor: 5.115

8.  Risk of symptomatic brain tumor recurrence and neurologic deficit after radiosurgery alone in patients with newly diagnosed brain metastases: results and implications.

Authors:  William F Regine; Jennifer L Huhn; Roy A Patchell; William H St Clair; James Strottmann; Ali Meigooni; Michael Sanders; A Byron Young
Journal:  Int J Radiat Oncol Biol Phys       Date:  2002-02-01       Impact factor: 7.038

9.  Incidence of brain atrophy and decline in mini-mental state examination score after whole-brain radiotherapy in patients with brain metastases: a prospective study.

Authors:  Yuta Shibamoto; Fumiya Baba; Kyota Oda; Shinya Hayashi; Masaki Kokubo; Shun-Ichi Ishihara; Yoshiyuki Itoh; Hiroyuki Ogino; Masahiko Koizumi
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-05-19       Impact factor: 7.038

10.  Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial.

Authors:  Eric L Chang; Jeffrey S Wefel; Kenneth R Hess; Pamela K Allen; Frederick F Lang; David G Kornguth; Rebecca B Arbuckle; J Michael Swint; Almon S Shiu; Moshe H Maor; Christina A Meyers
Journal:  Lancet Oncol       Date:  2009-10-02       Impact factor: 41.316

View more
  4 in total

1.  The treatment of patients with 1-3 brain metastases: is there a place for whole brain radiotherapy alone, yet? A retrospective analysis.

Authors:  Michela Buglione; Sara Pedretti; Stefano Gipponi; Luciano Buttolo; Paolo Panciani; Pietro Luigi Poliani; Roberto Liserre; Paolo Borghetti; Ludovica Pegurri; Loredana Costa; Luca Triggiani; Nadia Pasinetti; Paolo Ghirardelli; Sara Pandini; Alessandro Padovani; Stefano Maria Magrini
Journal:  Radiol Med       Date:  2015-04-28       Impact factor: 3.469

2.  Impact of radiosurgical management of geriatric patients with brain metastases: Clinical and quality of life outcomes.

Authors:  David M Randolph; Emory McTyre; Heidi Klepin; Ann M Peiffer; Diandra Ayala-Peacock; Scott Lester; Adrian W Laxton; Ammoren Dohm; Stephen B Tatter; Edward G Shaw; Michael D Chan
Journal:  J Radiosurg SBRT       Date:  2017

3.  Prediction Models for Radiation-Induced Neurocognitive Decline in Adult Patients With Primary or Secondary Brain Tumors: A Systematic Review.

Authors:  Fariba Tohidinezhad; Dario Di Perri; Catharina M L Zegers; Jeanette Dijkstra; Monique Anten; Andre Dekker; Wouter Van Elmpt; Daniëlle B P Eekers; Alberto Traverso
Journal:  Front Psychol       Date:  2022-03-31

Review 4.  Cognitive effects of stereotactic radiosurgery in adult patients with brain metastases: A systematic review.

Authors:  Wietske C M Schimmel; Karin Gehring; Daniëlle B P Eekers; Patrick E J Hanssens; Margriet M Sitskoorn
Journal:  Adv Radiat Oncol       Date:  2018-07-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.